BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

trial commencement, page-10

  1. 10,548 Posts.
    Yes Peace....BN006 could well be the dark horse indeed.
    From the latest release ;

    --------
    “Understanding the mechanism of action of BN006 may point the way to an entirely new class of therapeutic agent for this category of disease,” Prof Flower said.( He is a world renowned expert ) .

    The collaboration is funded under Bone Medical’s recently completed recapitalization and the results will potentially position BN006 for Phase 1 human trials in the near future.
    The top three products for auto-immune diseases like RA sold over US$25 billion in 2012.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.